Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Jun;333(2):163-7.
doi: 10.1007/BF00506520.

Relationship of metabolism of 2'-, 3'- and 5'-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferens

Relationship of metabolism of 2'-, 3'- and 5'-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferens

D R Webster et al. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun.

Abstract

In the isolated rat vas deferens stimulated at 0.2 Hz, a series of 2'-, 3'-, and 5'-substituted adenine nucleotides all inhibited the twitch responses, their actions being potentiated by the nucleoside transport inhibitors, HNBTGR, NBMPR and dipyridamole. The metabolism of these nucleotides was examined utilizing HPLC analysis of the bathing medium after exposure to 30 microM nucleoside or nucleotide for 5 min. 5'-AMP, 5'-ADP, 5'-ATP, and NAD+ were all partially hydrolysed to adenosine, the relative extent of this being 5'-AMP greater than 5'-ADP = 5'-ATP greater than NAD+. However, the other nucleotides examined were not detectably converted to adenosine or to adenosine deamination products. These results indicate that the 2'-, 3'- and 5'-substituted nucleotides studied act at a P1-purinoceptor in rat vas deferens to inhibit neurotransmission and, with the exception of 5'-AMP, 5'-ADP, 5'-ATP and NAD+, all appear to act directly at this receptor. However, the 5'-adenine nucleotides (AMP, ADP and ATP) and NAD+ all appear to act at least partially indirectly subsequent to their hydrolysis to adenosine.

PubMed Disclaimer

References

    1. J Pharmacol Exp Ther. 1984 May;229(2):564-70 - PubMed
    1. J Pharmacol Exp Ther. 1976 May;197(2):379-90 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1981 Sep;317(2):110-4 - PubMed
    1. Br J Pharmacol. 1985 Apr;84(4):825-31 - PubMed
    1. J Neurochem. 1984 Dec;43(6):1610-5 - PubMed

Publication types

LinkOut - more resources